These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

233 related items for PubMed ID: 15870215

  • 1. Long-term follow-up of atherosclerotic renovascular disease. Beneficial effect of ACE inhibition.
    Losito A, Errico R, Santirosi P, Lupattelli T, Scalera GB, Lupattelli L.
    Nephrol Dial Transplant; 2005 Aug; 20(8):1604-9. PubMed ID: 15870215
    [Abstract] [Full Text] [Related]

  • 2. The rate of progression of renal disease may not be slower in women compared with men: a patient-level meta-analysis.
    Jafar TH, Schmid CH, Stark PC, Toto R, Remuzzi G, Ruggenenti P, Marcantoni C, Becker G, Shahinfar S, De Jong PE, De Zeeuw D, Kamper AL, Strangaard S, Levey AS.
    Nephrol Dial Transplant; 2003 Oct; 18(10):2047-53. PubMed ID: 13679479
    [Abstract] [Full Text] [Related]

  • 3. Long-term renal function preservation after renal artery stenting in patients with progressive ischemic nephropathy.
    Rocha-Singh KJ, Ahuja RK, Sung CH, Rutherford J.
    Catheter Cardiovasc Interv; 2002 Oct; 57(2):135-41. PubMed ID: 12357507
    [Abstract] [Full Text] [Related]

  • 4. Worsening renal failure in older chronic kidney disease patients with renal artery stenosis concurrently on renin angiotensin aldosterone system blockade: a prospective 50-month Mayo-Health-System clinic analysis.
    Onuigbo MA, Onuigbo NT.
    QJM; 2008 Jul; 101(7):519-27. PubMed ID: 18375475
    [Abstract] [Full Text] [Related]

  • 5. Long-term survival after surgical revascularization for atherosclerotic renal artery disease.
    Steinbach F, Novick AC, Campbell S, Dykstra D.
    J Urol; 1997 Jul; 158(1):38-41. PubMed ID: 9186318
    [Abstract] [Full Text] [Related]

  • 6. Factors affecting long-term survival following renal artery stenting.
    Bates MC, Campbell JE, Stone PA, Jaff MR, Broce M, Lavigne PS.
    Catheter Cardiovasc Interv; 2007 Jun 01; 69(7):1037-43. PubMed ID: 17525962
    [Abstract] [Full Text] [Related]

  • 7. A prospective study of the determinants of renal functional outcome and mortality in atherosclerotic renovascular disease.
    Wright JR, Shurrab AE, Cheung C, Waldek S, O'Donoghue DJ, Foley RN, Mamtora H, Kalra PA.
    Am J Kidney Dis; 2002 Jun 01; 39(6):1153-61. PubMed ID: 12046025
    [Abstract] [Full Text] [Related]

  • 8. Renal failure and concurrent RAAS blockade in older CKD patients with renal artery stenosis: an extended Mayo Clinic prospective 63-month experience.
    Onuigbo MA, Onuigbo NT.
    Ren Fail; 2008 Jun 01; 30(4):363-71. PubMed ID: 18569908
    [Abstract] [Full Text] [Related]

  • 9. Long-term progression of chronic renal insufficiency in the AIPRI Extension Study. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group.
    Locatelli F, Carbarns IR, Maschio G, Mann JF, Ponticelli C, Ritz E, Alberti D, Motolese M, Janin G, Zucchelli P.
    Kidney Int Suppl; 1997 Dec 01; 63():S63-6. PubMed ID: 9407424
    [Abstract] [Full Text] [Related]

  • 10. Survival of patients with renovascular disease and ACE inhibition.
    Losito A, Gaburri M, Errico R, Parente B, Cao PG.
    Clin Nephrol; 1999 Dec 01; 52(6):339-43. PubMed ID: 10604640
    [Abstract] [Full Text] [Related]

  • 11. Implications of acute functional injury following percutaneous renal artery intervention.
    Davies MG, Saad WE, Peden EK, Mohiuddin IT, Naoum JJ, Lumsden AB.
    Ann Vasc Surg; 2008 Nov 01; 22(6):783-9. PubMed ID: 18692990
    [Abstract] [Full Text] [Related]

  • 12. Preservation of renal function with surgical revascularization in patients with atherosclerotic renovascular disease.
    Marone LK, Clouse WD, Dorer DJ, Brewster DC, Lamuraglia GM, Watkins MT, Kwolek CJ, Cambria RP.
    J Vasc Surg; 2004 Feb 01; 39(2):322-9. PubMed ID: 14743131
    [Abstract] [Full Text] [Related]

  • 13. The prognostic value of renal dysfunction in patients with chronic heart failure: 12-month follow-up.
    Roik M, Starczewska MH, Stawicki S, Solarska-Półchłopek A, Warszawik O, Oreziak A, Kochanowski J, Kosior D, Opolski G.
    Kardiol Pol; 2006 Jul 01; 64(7):704-11; discussion 712. PubMed ID: 16886127
    [Abstract] [Full Text] [Related]

  • 14. Predictive factors and therapeutic approach of renovascular disease: four years' follow-up.
    Ziakka S, Ursu M, Poulikakos D, Papadopoulos C, Karakasis F, Kaperonis N, Papagalanis N.
    Ren Fail; 2008 Jul 01; 30(10):965-70. PubMed ID: 19016147
    [Abstract] [Full Text] [Related]

  • 15. The association among renal insufficiency, pharmacotherapy, and outcomes in 6,427 patients with heart failure and coronary artery disease.
    Ezekowitz J, McAlister FA, Humphries KH, Norris CM, Tonelli M, Ghali WA, Knudtson ML, APPROACH Investigators.
    J Am Coll Cardiol; 2004 Oct 19; 44(8):1587-92. PubMed ID: 15489090
    [Abstract] [Full Text] [Related]

  • 16. [Predictors of successful renal artery revascularization in atherosclerotic renovascular disease].
    Flisiński M, Manitius J.
    Pol Merkur Lekarski; 2005 Aug 19; 19(110):206-10. PubMed ID: 16245436
    [Abstract] [Full Text] [Related]

  • 17. Does coronary artery bypass graft surgery improve survival among patients with end-stage renal disease?
    Dewey TM, Herbert MA, Prince SL, Robbins CL, Worley CM, Magee MJ, Mack MJ.
    Ann Thorac Surg; 2006 Feb 19; 81(2):591-8; discussion 598. PubMed ID: 16427858
    [Abstract] [Full Text] [Related]

  • 18. Effects of gender, Helicobacter pylori and hepatitis B virus serology status on cardiovascular and renal complications in Chinese type 2 diabetic patients with overt nephropathy.
    Lo MK, Lee KF, Chan NN, Leung WY, Ko GT, Chan WB, So WY, Ng MC, Ho CS, Tam JS, Lam CW, Tong PC, Chan JC.
    Diabetes Obes Metab; 2004 May 19; 6(3):223-30. PubMed ID: 15056131
    [Abstract] [Full Text] [Related]

  • 19. Lower progression rate of end-stage renal disease in patients with peripheral arterial disease using statins or Angiotensin-converting enzyme inhibitors.
    Feringa HH, Karagiannis SE, Chonchol M, Vidakovic R, Noordzij PG, Elhendy A, van Domburg RT, Welten G, Schouten O, Bax JJ, Berl T, Poldermans D.
    J Am Soc Nephrol; 2007 Jun 19; 18(6):1872-9. PubMed ID: 17475817
    [Abstract] [Full Text] [Related]

  • 20. Cytotoxic therapy for membranous nephropathy and renal insufficiency: improved renal survival but high relapse rate.
    du Buf-Vereijken PW, Branten AJ, Wetzels JF, Membranous Nephropathy Study Group.
    Nephrol Dial Transplant; 2004 May 19; 19(5):1142-8. PubMed ID: 14993502
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.